Capital International Sarl Legend Biotech Corp Transaction History

Capital International Sarl

  • $4.2 Billion
  • Q1 2025

A detailed history of Capital International Sarl transactions in Legend Biotech Corp stock. As of the latest transaction made, Capital International Sarl holds 35,093 shares of LEGN stock, worth $1.06 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
35,093
Previous 54,333 35.41%
Holding current value
$1.06 Million
Previous $1.77 Million 32.65%
% of portfolio
0.03%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$31.43 - $39.7 $604,713 - $763,828
-19,240 Reduced 35.41%
35,093 $1.19 Million
Q4 2024

Feb 13, 2025
SELL
$32.49 - $50.28 $292,572 - $452,771
-9,005 Reduced 14.22%
54,333 $1.77 Million
Q3 2024

Nov 13, 2024
SELL
$43.55 - $59.88 $1.33 Million - $1.82 Million
-30,448 Reduced 32.47%
63,338 $3.09 Million
Q2 2024

Aug 13, 2024
BUY
$39.5 - $57.22 $426,007 - $617,117
10,785 Added 12.99%
93,786 $4.15 Million
Q4 2023

Feb 13, 2024
SELL
$57.25 - $69.74 $11,450 - $13,947
-200 Reduced 0.24%
83,001 $4.99 Million
Q3 2023

Nov 13, 2023
BUY
$63.16 - $76.5 $446,667 - $541,008
7,072 Added 9.29%
83,201 $5.59 Million
Q2 2023

Aug 11, 2023
BUY
$46.28 - $75.01 $165,451 - $268,160
3,575 Added 4.93%
76,129 $5.26 Million
Q1 2023

May 15, 2023
SELL
$43.42 - $57.37 $58,790 - $77,678
-1,354 Reduced 1.83%
72,554 $3.5 Million
Q4 2022

Feb 14, 2023
SELL
$38.8 - $55.46 $3.25 Million - $4.64 Million
-83,721 Reduced 53.11%
73,908 $3.69 Million
Q3 2022

Nov 14, 2022
BUY
$38.15 - $57.1 $81,221 - $121,565
2,129 Added 1.37%
157,629 $6.43 Million
Q2 2022

Aug 15, 2022
SELL
$33.54 - $55.0 $2.36 Million - $3.87 Million
-70,380 Reduced 31.16%
155,500 $8.55 Million
Q1 2022

May 16, 2022
SELL
$31.02 - $48.18 $584,820 - $908,337
-18,853 Reduced 7.7%
225,880 $8.21 Million
Q4 2021

Feb 14, 2022
BUY
$41.14 - $56.98 $953,254 - $1.32 Million
23,171 Added 10.46%
244,733 $11.4 Million
Q3 2021

Nov 15, 2021
BUY
$35.31 - $50.56 $38,558 - $55,211
1,092 Added 0.5%
221,562 $11.2 Million
Q2 2021

Aug 16, 2021
BUY
$25.8 - $41.09 $1.24 Million - $1.97 Million
47,924 Added 27.77%
220,470 $9.05 Million
Q1 2021

May 14, 2021
SELL
$23.55 - $32.4 $2.86 Million - $3.94 Million
-121,594 Reduced 41.34%
172,546 $5.01 Million
Q4 2020

Feb 16, 2021
SELL
$25.8 - $32.39 $224,976 - $282,440
-8,720 Reduced 2.88%
294,140 $8.28 Million
Q3 2020

Nov 16, 2020
SELL
$27.5 - $39.61 $347,875 - $501,066
-12,650 Reduced 4.01%
302,860 $9.35 Million
Q2 2020

Aug 14, 2020
BUY
$36.1 - $42.56 $11.4 Million - $13.4 Million
315,510 New
315,510 $13.4 Million

Others Institutions Holding LEGN

# of Institutions
229
Shares Held
74.4M
Call Options Held
247K
Put Options Held
406K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.03B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Capital International Sarl Portfolio

Follow Capital International Sarl and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Sarl with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email